Home › Breast Cancer › NCT06115486

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

EXERT-BCH: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer to Improve Hypertrophy

Who can join

Ages 20 to 89 · Women

Inclusion Criteria:

Age 20-89 years

* Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast
* Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.

Exclusion Criteria:

* Any current treatment with cytotoxic chemotherapy for breast cancer
* Inability to safely engage in group sessions of resistance training as deemed by study PI
* Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training

About the study

The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

What is being tested

• Control Arm ACSM Guidelines (other)
• Experimental Arm 6-12-25 repetitions per set (other)

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Participants: 30 · Started: Jan 9, 2024

Contact the study team

• Clinical Trials Contact · Phone: 4123306151

Official record on ClinicalTrials.gov — NCT06115486

Locations in the U.S.

Conditions

• Breast Cancer
• Breast Carcinoma In Situ
• Cancer (all types)
• Carcinoma in Situ
• Hypertrophy

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.